Identification and Analysis of Amino Acid Mutations in Porin IB That Mediate Intermediate-Level Resistance to Penicillin and Tetracycline in Neisseria gonorrhoeae by Olesky, M. et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2002, p. 2811–2820 Vol. 46, No. 9
0066-4804/02/$04.000 DOI: 10.1128/AAC.46.9.2811–2820.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Identification and Analysis of Amino Acid Mutations in Porin IB
That Mediate Intermediate-Level Resistance to Penicillin and
Tetracycline in Neisseria gonorrhoeae
Melanie Olesky,1 Marcia Hobbs,2,3 and Robert A. Nicholas1*
Departments of Pharmacology1, Medicine,2 and Microbiology and Immunology,3 The University of North Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599-7365
Received 14 March 2002/Returned for modification 15 May 2002/Accepted 11 June 2002
PenB is the third resistance determinant in the stepwise acquisition of multiple resistance genes in chro-
mosomally mediated resistant Neisseria gonorrhoeae (CMRNG). Alterations in porIB, one of two alleles at the
por locus that encodes the outer membrane protein porin IB (PIB), were recently reported to be responsible for
the increased resistance to penicillin and tetracycline conferred by penB, but the specific mutations conferring
antibiotic resistance were not identified experimentally. To determine which amino acids in PIB confer
increased resistance, we transformed a recipient strain with chimeras of the porIB genes from strains FA1090
and FA140 (penB2). These studies revealed that two amino acid changes, G120D and A121D, were both
necessary and sufficient to confer increased resistance to penicillin and tetracycline. Site-saturation and
site-directed mutagenesis of Gly-120 and Ala-121 revealed that both a single mutation, G120K, and the double
mutations G120R A121H and G120P A121P also conferred antibiotic resistance to the recipient strain. The
identical mutations in PIA increased penicillin and tetracycline resistance either moderately or not at all.
Analysis of porIB genes present in the GenBank database from 51 clinical isolates demonstrated that lysine and
aspartate mutations at positions 120 and/or 121 also occur in nature. These studies demonstrate that charged
amino acids at positions 120 and 121 in PIB are highly preferential for conferring resistance to penicillin and
tetracycline in N. gonorrhoeae.
From 1945 to 1988, penicillin was the antibiotic of choice for
treatment of gonococcal infections. During this time, however,
the resistance of isolates gradually increased until treatment
failure with penicillin became widespread and penicillin was
discontinued as a first-line antibiotic. Resistance to other an-
tibiotics, including erythromycin and tetracycline, also in-
creased during this time. The antibiotics currently recom-
mended for treatment of gonococcal infections are expanded-
spectrum cephalosporins (i.e., ceftriaxone and cefixime) or
fluoroquinolones (7), but resistance to fluoroquinolones
threatens to make these antibiotics obsolete as well (8).
Resistance to penicillin and tetracycline in gonococci can be
either plasmid mediated or chromosomally mediated (5). Plas-
mid-mediated resistance to penicillin is due to the production
of a TEM-1-like -lactamase, whereas plasmid-mediated resis-
tance to tetracycline is due to expression of the TetM deter-
minant acquired from Streptococcus pneumoniae (34). In con-
trast, chromosomally mediated resistance to penicillin and
tetracycline in Neisseria gonorrhoeae results from the acquisi-
tion of multiple resistance genes, each of which confers an
incremental increase in resistance until the cell becomes re-
fractory to clinically achieved levels of the antibiotic. As dem-
onstrated by the work of Sparling and others (15, 18, 39), these
resistance genes can be transferred in the laboratory in a step-
wise manner from a resistant strain to a susceptible strain by
DNA uptake and homologous recombination.
The first determinant in the stepwise acquisition of penicillin
resistance is the penA gene, which encodes altered forms of
penicillin-binding protein 2 (PBP 2) that have a lower rate of
acylation by penicillin (15, 16, 40). Insertion of a single aspartic
acid residue preceding Asp-345 (Asp-345a) in PBP 2 is the
major cause of the decreased rate of acylation by penicillin,
although additional mutations in PBP 2 also contribute (2).
The second resistance determinant is the mtr (multiple trans-
ferable resistance) locus, which increases resistance to diverse
hydrophobic agents, including erythromycin and detergent-like
fatty-acids (24, 35, 39). Resistance to these agents is most
commonly due to a single base pair deletion in the regulatory
region of the mtrCDE locus that results in increased expression
of the energy-dependent Mtr efflux pump.
The third resistance determinant in chromosomally medi-
ated resistant N. gonorrhoeae (CMRNG) is penB, which in-
creases resistance to both penicillin and tetracycline. Previous
reports showed that the penB genetic locus was closely linked
to the por locus, which encodes an outer membrane porin
protein through which small molecules and solutes diffuse into
the periplasmic space (23). N. gonorrhoeae has two porins, PIA
and PIB, encoded by alleles of a single por locus (6). In 1980,
Cannon and colleagues observed a 98% cotransformation fre-
quency of porIB and the penB gene, suggesting that por was
separate from but closely linked to penB in the genome (4).
However, Gill et al. (20) recently reported that resistance con-
ferred by the penB gene in the intermediate-level penicillin-
resistant strain FA140 is due to mutations within the porIB
gene. The authors speculated that alterations in putative loop
3, which in the crystal structures of several porins is located
within the -barrel and forms the constriction of the pore, were
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responsible for increased resistance to antibiotics, but no ex-
perimental evidence was provided to support this hypothesis.
Studies with other porins have shown that mutations in other
regions can have significant effects on pore properties (31, 36).
In order to delineate more clearly the molecular mechanisms
of chromosomally mediated antibiotic resistance in N. gonor-
rhoeae, we set out to determine the specific amino acid alter-
ation(s) in PIB that confers resistance to penicillin and tetra-
cycline and to define the types of amino acids at these positions
that are capable of mediating resistance.
MATERIALS AND METHODS
Strains. N. gonorrhoeae strain FA1090 (5) and the third-level transformant
FA140 (FA19  FA48) (37) have been described previously. Strain FA19 penA4
mtr was derived from FA19 (38) by stepwise transformation with genomic DNA
from FA6140 (18). FA19 penA4 mtr (PIB) was constructed as described below.
Escherichia coli MC1061 cells were transformed with porIB-containing plasmids,
and colonies were grown on Luria-Bertani (LB) agar containing 50 g of kana-
mycin/ml, 350 g of erythromycin/ml, or 34 g of chloramphenicol/ml.
Construction of strain FA19 penA4 mtr (PIB). Attempts to transform the
coding sequence of porIB into a strain containing the porIA gene, i.e., FA19 penA4
mtr, were unsuccessful. Therefore, we generated a recipient strain of N. gonor-
rhoeae that contains the first two resistance determinants, penA4 and mtr, and the
FA1090 porIB gene to facilitate homologous recombination between donor and
recipient DNAs. The porIB gene was amplified from FA1090 genomic DNA with
Taq polymerase and transformed into strain FA19 penA4 mtr. The 5 primer
(por-S1, 5-CGAGCTCGCCGTCTGAACCATCTACCGCGCCGACCTTAC-
3) was complementary to a region 1,000 bp upstream of the porIB coding
sequence and contained at its 5 end a SacI restriction enzyme site (boldfaced)
and the specific 10-bp uptake sequence (US) (underlined) necessary for uptake
of DNA into gonococci (17, 21). The 3 primer (por-U1, 5-CGTCTGAGGCC
GTCTGAATATGGATAGATTCGTCATTCCCGC-3) was complementary to
a region 300 bp downstream of the porIB gene and contained both an US and
an XbaI restriction site at its 5 end. The 2.3-kb PCR amplification product was
subcloned into the SacI and XbaI sites of a modified pBluescript vector, pBSC-
KS, with the porIB gene in the direction opposite from the lac promoter.
pBSC-KS has the chloramphenicol resistance gene from pACYC184 (9) in place
of the -lactamase resistance gene and a deletion of the BglI site. The kanamycin
resistance gene was subsequently cloned into the unique BglI site located 40 bp
downstream of the porIB stop codon. FA19 penA4 mtr was transformed with this
plasmid, and transformants were selected on GCB agar plates containing 50 g
of kanamycin/ml. Replacement of the endogenous porIA gene with the FA1090
porIB gene was confirmed via sequencing of the por gene amplified by PCR from
genomic DNA (University of North Carolina—Chapel Hill [UNC-CH] Sequenc-
ing Facility).
Generation of porIB mutant constructs. The mature coding sequences (i.e.,
lacking the region encoding the 19-amino-acid leader sequence) of the porIB
gene from strains FA1090 and FA140 plus 300 bp of downstream sequence were
amplified from genomic DNA with por-U1 and a 5 primer (por-S2, CGAGCT
CGCCGTCTGAAGATGTCACCCTGTACGGTGCCATCAAA) complemen-
tary to bases 58 to 84 of the porIB gene. The 5 primer also contained an US and
a SacI restriction site at its 5 end. The PCR products were digested with SacI
and XbaI and subcloned into similarly digested pBSC-KS. Silent unique restric-
tion sites (HindIII, EcoRI, and ClaI) were incorporated into the FA1090 and
FA140 porIB genes at codons 110, 187, and 274, which surround the codon
differences between the two genes. porIB chimeras were constructed by digestion
and DNA fragment exchange. Constructs containing single or double mutations
were created via four-primer PCR (26) with the FA1090 porIB gene as a tem-
plate. To aid in selection, the erythromycin resistance gene (ermC) was inserted
into the unique BglI site of the plasmids as described above for the kanamycin
resistance gene. All constructs were verified by sequencing.
A library of porIB genes containing randomized codons at positions 120 and
121 was also generated by four-primer PCR. The porIB gene from strain FA1090
containing the silent restriction sites was used as the template in the first set of
reactions. The external primers were por-S2 and por-U1. The internal down
primer (5-384GGATTCCCAAGCATTGACGTTNNNNNNGGTGTTTTTCA
GGGGGCTGTT337-3) contained an equal mixture of all four nucleotides at the
six base positions encoding amino acids 120 and 121 in PIB and 21 bases of porIB
sequence on either side. The internal up primer (5-364AACGTCAATGCTTG
GGAATCC384-3) was complementary to 21 bases of por DNA on the 5 end of
the randomized sequence. Sequencing of an aliquot of the final PCR product
verified that all four nucleotides were represented equally at each of the six
randomized positions. The PCR products were either used directly to transform
gonoccocal cells or ligated into pBSC-KS. For the latter, E. coli MC1061 cells
were transformed with the ligation mixture, and a plasmid library was selected in
LB broth with chloramphenicol. Sequencing of an aliquot of the library again
confirmed the presence of all four bases at roughly equal intensities at each of
the six randomized positions.
PCR amplification of the porIB gene from transformants. Colonies were re-
suspended in 50 l of distilled H2O and boiled for 10 min, and 5-l aliquots were
used as the DNA template for PCR with Taq DNA polymerase. PCR primers
were por-S1 and por-U1. Amplification conditions were 94°C for 5 min; 30 cycles
of 94°C for 30 s, 59°C for 30 s, and 72°C for 1 min, 15 s; and a final extension of
72°C for 7 min. For all recombinants, the entire amplified gene was sequenced to
verify homologous recombination of the mutation(s).
Genetic transformation. N. gonorrhoeae was transformed as described previ-
ously (38). Briefly, cells were passaged on GCB agar, and a single piliated colony
was streaked onto a fresh GCB plate and allowed to grow overnight. Cells were
scraped from the plate and gently resuspended to a cell density of 108/ml (optical
density at 560 nm, 0.18) in prewarmed GC broth containing 10 mM MgCl2 and
supplements I and II (29). Following addition of NaHCO3 to a final concentra-
tion of 10 mM, aliquots (900 l) of diluted cells were mixed with 100 l of 5- to
50-g/ml donor DNA in 1 SSC (0.15 M NaCl plus 0.015 M sodium citrate) and
incubated for 5 h at 37°C under a humidified 5% CO2 atmosphere. Cells were
plated on GCB agar with the appropriate antibiotic and grown for 24 to 48 h at
37°C under 5% CO2. Alternatively, cells at 104, 103, or 102 CFU/ml were incu-
bated with 5 to 50 g of DNA on GCB agar for 16 to 20 h and then transferred
to selection plates (22).
MIC assays. N. gonorrhoeae colonies were suspended in GCB broth to a
density of 104/l, and 5 l was spotted onto GCB agar plates (15) containing
increasing concentrations of penicillin (0.06, 0.125, 0.3, 0.35, 0.4, 0.5, 0.75, and 1.0
g/ml) or tetracycline (0.156, 0.313, 0.45, 0.625, 0.75, 1.0, and 1.5 g/ml). The
plates were then incubated at 37°C under 5% CO2 for 24 h. Alternatively, cells
were resuspended in GCB broth, and 1,000 colonies were spread to GCB agar
plates containing increasing concentrations of either penicillin or tetracycline.
The MIC was defined as the minimal concentration of antibiotic at which no
more than 5 colonies were observed after 24 h. The two methods gave very
similar results. MICs are presented as average values from at least four separate
experiments.
Growth assay. N. gonorrhoeae cells were plated onto GCB agar plates from
frozen stocks and grown overnight at 37°C under 5% CO2. Nonpiliated colonies
were passaged on GCB plates and grown for 16 to 20 h. Cells were gently scraped
from the plates and suspended at a final density of 14 Klett units per 10 ml of
GCB broth plus supplements I and II. Side-arm flasks containing the bacterial
suspensions were shaken at 37°C under 5% CO2, and cell densities were mea-
sured every hour with a Klett reader.
SDS-PAGE and Western blotting. N. gonorrhoeae cells were scraped from
GCB agar plates and diluted to 5  107 CFU/ml in GC broth. The cells were
pelleted, suspended in 45 l of 1 Laemmli buffer, and heated at 80°C for 5 min.
Four microliters of the cell lysates was loaded onto two 10% polyacrylamide gels,
and total proteins were separated via sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). One of the gels was stained with Coomassie bril-
liant blue R-250, while the other gel was electroblotted onto nitrocellulose
membranes in transfer buffer (25 mM Tris, 192 mM glycine, 10% methanol,
0.01% SDS [pH 8.3]). The membrane was probed sequentially with H5 mono-
clonal antisera, which recognize FA1090 porin protein (a gift from Janne Can-
non, UNC-CH), and an anti-mouse secondary antibody conjugated to horserad-
ish peroxidase. Porin proteins were visualized by incubation with Supersignal
chemiluminescent substrate (Pierce/Endogen, Rockford, Ill.).
Outer membranes. N. gonorrhoeae outer membranes were purified as de-
scribed by Lamden and Heckels (30). Briefly, cells were scraped from GCB agar
plates and suspended in 5 ml of lithium acetate buffer (0.2 M lithium chloride, 0.1
M sodium acetate, 0.01 M EDTA [pH 5.8]). The cells were broken by 15 passages
through a 22-gauge needle. Cell debris was pelleted at low speed (11,000  g),
and outer membranes were pelleted at 100,000  g for 2 h. Protein levels were
determined via a modified Bradford assay. Four micrograms of outer membrane
proteins in 1 Laemmli sample buffer was incubated either at room temperature
or at 80°C for 5 min and subjected to SDS-PAGE. Western blotting was per-
formed to detect monomeric and trimeric forms of the porin proteins by use of
the H5 monoclonal antisera to the FA1090 porin protein as described for whole-
cell lysates.
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RESULTS
Identification of specific mutations in FA140 PIB that con-
fer intermediate-level resistance to penicillin and tetracycline.
The PIB proteins of strains FA1090 and FA140 (penA2 mtr
penB2) differ by 10 amino acids (Fig. 1A), but only the porin
from FA140 confers intermediate levels of penicillin and tet-
racycline resistance. To determine which of these 10 amino
acid differences is (are) responsible for conferring resistance to
penicillin and tetracycline, we created silent unique restriction
sites surrounding the sequences encoding these amino acids to
allow construction of porin chimeras and to aid in identifying
strains transformed with the recombinant genes (Fig. 1A).
Chimera 1 was created by fusing codons 1 to 187 of FA140
porin (containing three alterations) to codons 188 to 349 (con-
taining seven alterations) of FA1090 porin, while chimera 2
was the reverse, beginning with the PIB sequence from
FA1090 and switching to the FA140 sequence at codon 188
(Fig. 1B). A novel strain of N. gonorrhoeae, FA19 penA4 mtr
(PIB), which contains the first two resistance determinants
from FA6140 and the porIB gene from FA1090, was con-
structed to serve as the recipient strain for transformation
experiments with the chimeras (as described in Materials and
Methods).
FA19 penA4 mtr (PIB) was transformed with the porIB chi-
FIG. 1. FA1090 and FA140 PIB proteins. (A) HindIII, EcoRI, and ClaI silent restriction sites were inserted at codons 110, 187, and 274,
respectively, flanking the amino acid differences between the PIB proteins of strains FA1090 and FA140. Residues 1 to 19 constitute the cleavable
signal sequence. (B) porIB chimeras were generated via DNA sequence exchange at the EcoRI site.
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meras, and transformants were selected on GCB agar plates
containing 0.55 g of tetracycline/ml. Transformation with
genomic DNA isolated from strain FA140 (positive control)
gave rise to resistant colonies at a frequency of 8  105.
Transformation with chimera 1 (FA14019-187/FA1090188-349
porIB) resulted in the growth of tetracycline-resistant colonies
at a frequency of 4  105, whereas transformation with chi-
mera 2 (FA109019-187/FA140188-349 porIB) failed to generate
resistant colonies. Thus, only transformation with the chimera
encoding the FA140 porIB N-terminal sequence resulted in
tetracycline-resistant colonies on selection plates. Nine of 10
porIB genes amplified by PCR from separate transformants
showed the expected digestion pattern with HindIII and
EcoRI, confirming that genomic recombination had occurred.
Sequencing of the PIB gene from the one clone that did not
show the expected digestion pattern revealed that it differed
from the PIB of the recipient strain by only 2 amino acids,
G120D and A121D. MICs of penicillin and tetracycline for
each of the 10 transformants were the same as for strains
obtained by transformation with the complete FA140 sequence
(Fig. 2). Thus, alteration of the amino acids at positions 120
and 121 (Gly and Ala, respectively) to aspartic acid is sufficient
to confer the same level of resistance to penicillin and tetra-
cycline as the PIB from FA140.
To verify that other residues in FA140 PIB do not contribute
to the penB phenotype, FA19 penA4 mtr (PIB) was trans-
formed with a plasmid containing the FA1090/FA140 porIB
chimera (chimera 2) and a linked erythromycin resistance gene
(ermC) to aid in the selection of transformed colonies. The
ermC gene was incorporated into the plasmid downstream of
the porIB stop codon and was flanked on its 3 end by 300 bp of
N. gonorrhoeae sequence. Recombination within the por gene
in the erythromycin-resistant transformants was confirmed by
PCR amplification and restriction digestion. The resistance to
penicillin and tetracycline of the resultant strain was essentially
identical to that of the recipient strain (Fig. 2). Thus, these
data further confirm that mutations at positions 120 and 121
are the only changes capable of conferring increased resis-
tance.
To determine whether aspartic acid mutations at both resi-
dues were necessary to confer full resistance to penicillin and
tetracycline, FA1090 porIB constructs containing either a single
G120D or a single A121D amino acid alteration and the flank-
ing ermC gene were generated and used to transform FA19
penA4 mtr (PIB) to erythromycin resistance. Following confir-
mation by sequencing that the mutations had recombined into
the genome, MIC analysis revealed that mutation of either
Gly-120 or Ala-121 in PIB to aspartic acid conferred a mod-
erate increase in resistance to penicillin and tetracycline over
that of the recipient strain (Fig. 2). However, resistance to
either antibiotic was 1.5-fold lower than that of strains harbor-
ing aspartic acid mutations at both positions. Therefore, both
the G120D and the A121D mutation are necessary to confer
full resistance to penicillin and tetracycline.
FIG. 2. MICs of penicillin and tetracycline for N. gonorrhoeae strains harboring porIB chimeras. Solid bars represent MICs for the recipient
strain, FA19 penA4 mtr (PIB), and the isogenic strain, FA19 penA4 mtr penB, which contains the PIB from strain FA140. Strains with PIB chimeras
(striped bars) and strains with a single aspartate mutation at position 120 or 121 (open bars) were created by transformation of strain FA19 penA4
mtr (PIB) with mutant porIB DNA. MICs shown are averages from five experiments. Error bars, standard deviations. Dashed lines denote the
respective MICs for the recipient strain.
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Isolation of penicillin- and tetracycline-resistant strains
transformed with porIB DNA containing randomized codons at
positions 120 and 121. To determine the importance of specific
amino acid mutations in PIB proteins at residues 120 and 121,
we randomized the codons at positions 120 and 121 by multi-
plex PCR and used these constructs to transform the recipient
strain to increased penicillin or tetracycline resistance. Trans-
formants were selected on GCB plates containing either 0.57
g of tetracycline/ml or 0.37 g of penicillin/ml, and 20 isolates
were chosen for further analysis. The MIC of penicillin for
each transformant was 0.75 g/ml, identical to that for the
strain with G120D and A121D double PIB mutations. How-
ever, the MIC of tetracycline for all 20 transformants was 1.5
g/ml, compared with 1.0 g/ml for the strain with the double
aspartic acid PIB mutations. The porIB genes from each of the
20 resistant transformants were amplified by PCR and se-
quenced. Eighteen porIB genes harbored a lysine codon at
residue 120, while one other had an arginine at that position
(Table 1). Eight different charged and uncharged amino acids
were found at residue 121. We also isolated one transformant
with prolines at both residues 120 and 121. Overall, these data
suggest that mutations at positions 120 and/or 121, particularly
to charged amino acids, confer intermediate-level resistance to
penicillin and tetracycline.
Analysis of charged and uncharged amino acid mutations at
positions 120 and 121 in PIB. We also mutated Gly-120 and
Ala-121 to several charged amino acids to investigate further
the role of charged side chains in conferring resistance to
penicillin and tetracycline. FA19 penA4 mtr (PIB) was trans-
formed with porIB constructs containing either a G120H,
G120E, G120K, or A121K mutation and the linked erythro-
mycin resistance gene, and cells were selected on plates con-
taining 6.0 g of erythromycin/ml. The MICs of penicillin and
tetracycline for the strain containing the G120H PIB mutation
were essentially identical to those for the recipient strain,
whereas the MICs for the strain with the G120E PIB mutation
were similar to those of strains harboring either the G120D or
the A121D single PIB mutation (Fig. 3). Mutation of Gly-120
to Lys conferred the same level of resistance to the recipient
strain as each of the random mutants containing a G120K
mutation, whereas mutation of Ala-121 to Lys conferred only
moderate resistance to both antibiotics (Fig. 3). These data
demonstrate that a single mutation of G120 to lysine in PIB is
the only change needed to confer full intermediate-level resis-
tance to penicillin and tetracycline, which is consistent with the
results from our randomized screen.
To investigate the consequences of side chain charge versus
FIG. 3. MICs of penicillin and tetracycline for N. gonorrhoeae strains harboring single-amino-acid mutations in PIB. Strains with the single-
amino-acid mutation G120H, G120E, G120K, or A121K in PIB were created by transformation of strain FA19 penA4 mtr (PIB) with altered porIB
constructs. MICs are averages from five experiments. Error bars, standard deviations. Dashed lines denote the respective MICs for the recipient
strain, FA19 penA4 mtr (PIB).
TABLE 1. Amino acid residues at positions 120 and 121 in PIB
proteins from strains isolated from transformation of FA19 penA4
mtr (PIB) with porIB DNA harboring randomized codon mutations
at these positions
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size in mediating resistance to penicillin and tetracycline, PIB
constructs with uncharged amino acids at positions 120 and 121
(G120L A121L or G120N A121N) were transformed into the
recipient strain. Leucine or asparagine residues were chosen
because their sizes closely resemble those of their charged
counterparts lysine and aspartic acid, respectively. The MICs
of penicillin and tetracycline for the strains with these double
PIB mutations were essentially identical to those of the recip-
ient strain (data not shown), demonstrating that the charge of
the side chain, and not its size, is the most important attribute
for conferring resistance to the two antibiotics.
Rate of growth of N. gonorrhoeae strains. Because mutations
in residues 120 and 121 apparently alter the flux of antibiotics
across the outer membrane, we determined whether these al-
terations might also alter the passage of metabolites. There-
fore, we compared the growth rate of the recipient strain,
FA19 penA4 mtr (PIB), with those of isogenic strains contain-
ing either the G120K or the G120D A121D PIB mutations. All
strains exhibited similar growth curves and growth rates in
GCB broth over three separate experiments (data not shown).
Doubling times were 1.27  0.06 h for the strain with the
FA1090 PIB, 1.13  0.06 h for the G120D A121D PIB mutant,
and 1.18  0.03 h for the G120K PIB mutant. Therefore,
mutations at residues 120 and/or 121 in PIB do not appear to
compromise the growth rate of the cell, at least in GCB me-
dium.
Determination of porin expression levels in penB strains. To
determine whether the mutations in PIB altered either the
level of porin expression or the propensity of the porin mono-
mers to form trimers at the cell surface, we compared the levels
of PIB protein expressed in strain FA19 penA4 mtr (PIB) to
those in strains expressing PIB with G120K, G120D A121D,
G120K A121R, or G120P A121P mutations. Coomassie blue
staining (Fig. 4A) and Western blotting (data not shown) of
whole-cell lysates showed no detectable differences in PIB ex-
pression among the tested strains over several experiments. To
test the effects of the mutations on the integrity of porin tri-
mers, outer membranes from the recipient and penB strains
were incubated in SDS-PAGE loading buffer either at room
temperature or at 80°C and subjected to SDS-PAGE. Protein
staining with Coomassie blue indicated that porin trimers were
present in equal amounts in all of the strains examined when
they were incubated at room temperature and completely dis-
sociated into monomers at 80°C (Fig. 4B). These results were
further confirmed by immunoblotting (data not shown). Taken
together, these data suggest that resistance to penicillin and
tetracycline in penB strains is not a result of altered porin levels
or the propensity of the porin to form trimers at the cell
surface but is presumably due to alterations in the porin chan-
nel itself.
The G120K mutation in PIA confers increased penicillin
and tetracycline resistance. N. gonorrhoeae has two porins,
PIA and PIB, whose genes are alleles of a single locus (6). To
date, increased resistance to penicillin and tetracycline in penB
isolates has been correlated only with alterations in PIB and
not with alterations in PIA. Since these proteins are 67%
identical, we investigated whether mutation of Gly-120 to ly-
sine in loop 3 of PIA, which is the residue equivalent to Gly-
120 in PIB (Fig. 5), could also confer resistance to penicillin
and tetracycline. FA19 penA4 mtr was transformed with porIA
mutant DNA, and transformants were selected at a frequency
of 1.6  105 on GCB plates containing 0.24 g of penicillin/
ml. MIC analysis of the transformed strain revealed that while
the G120K mutation in PIA increases both tetracycline and
penicillin resistance over that of the recipient strain, it does not
increase resistance to the same levels as an isogenic strain
harboring the G120K mutation in PIB (Fig. 6). This was espe-
cially evident in the levels of tetracycline resistance. FA19
penA4 mtr was also transformed with porIA G120D G121D
DNA. The resultant strain showed only a small increase in
resistance to penicillin and no increase in resistance to tetra-
cycline (Fig. 6). These data suggest that structural differences
in loop 3 or potentially in the barrel regions between PIB and
PIA are critical for these mutations to increase resistance.
Identification of PIB amino acid mutations at residues 120
and 121 in clinical strains. To determine the prevalence of
naturally occurring charged amino acids at PIB positions 120
and 121, we examined the loop 3 sequences of 51 clinical
isolates whose por sequences are present in the GenBank da-
tabase (11, 19, 27). These strains represented 14 distinct PIB
serovars and separate geographical locations, including the
United States, Singapore, Great Britain, and Kenya. Of these,
15 strains (29.4%) had lysine and aspartate codons at positions
120 and 121, respectively, 6 strains (11.8%) had an aspartate
residue at position 120 or 121, and 3 strains (5.9%) harbored
aspartate codons at both positions. We also analyzed the loop
3 sequences of 45 PIA proteins. At residue 120, 21 strains
(46.6%) had an aspartate residue whereas the rest of the iso-
lates had a glycine. Only a glycine was seen at position 121.
These data indicate that mutations of residues 120 and/or 121
are common in clinical isolates, especially mutations to
charged amino acids.
DISCUSSION
The focus of this study was to investigate the structure-
function aspects of porin-mediated resistance in N. gonor-
rhoeae. We showed that alteration of residues 120 and 121 of
PIB to aspartic acids confers intermediate-level resistance to
penicillin and tetracycline. We also showed that a single-ami-
no-acid mutation in PIB, G120K, is sufficient to confer full
intermediate-level antibiotic resistance when expressed in a
penA mtr recipient strain. Moreover, lysine and aspartic acid
residues were found at positions 120 and/or 121 in the PIB
proteins of approximately 47% of clinical isolates in the Gen-
Bank database, indicating that these changes occur in nature.
Our data demonstrated that mutations in PIB at positions
120 and/or 121, particularly to charged amino acids, are capa-
ble of conferring antibiotic resistance in N. gonorrhoeae. A
single Asp mutation at either position 120 or 121 conferred
only partial resistance to the antibiotics, showing that Asp
mutations at both these positions were necessary for conferring
the same level of resistance as the FA140 PIB. Moreover,
mutation of Gly-120 to Glu conferred similar levels of resis-
tance to the recipient strain as PIB containing a single Gly-
120-to-Asp mutation. Although we did not examine the effects
of double Glu mutations at positions 120 and 121 on resis-
tance, we suspect that this mutant would show levels of resis-
tance similar to those of the double Asp mutant. In contrast,
only a single G120K mutation was necessary to confer the same
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level of penicillin resistance and even higher levels of tetracy-
cline resistance to the recipient strain. The latter observation
explains both the abundance of lysine and the lack of aspar-
tates in the randomized library screen. The expected frequency
of selecting a single lysine codon at position 120 is 1 of 32
(since 2 of 64 codons encode lysine) compared to 1 of 1,024 for
transformants harboring aspartic acid codons at both positions
[the product of the frequency of aspartate codons at each
position, (1/32)2].
Gram-negative bacteria have developed two main porin-
mediated mechanisms to increase resistance to antibiotics.
One of these mechanisms, in which the bacteria become resis-
tant to antibiotics following a loss of porin expression, is ob-
served in many gram-negative bacteria, including Pseudomonas
aeruginosa and Klebsiella pneumoniae (25, 32, 42). Because
certain antibiotics diffuse selectively through a particular porin,
loss of that porin species increases resistance to these antibi-
otics. The second porin-mediated mechanism, as described in
this study, utilizes structural alterations in porin channels that
presumably decrease the flux of antibiotics across the outer
membrane. The latter mechanism is utilized by N. gonorrhoeae
because it expresses only a single porin allele, and gonococci
lacking porin are not viable (6). Interestingly, Enterobacter
aerogenes has been reported to increase resistance to antibiot-
ics via both mechanisms (10, 13).
Previous protein sequence alignments of N. gonorrhoeae PIB
with other porins placed residues 120 and 121 in loop 3, which
folds into the lumen of the barrel and constricts the porin
FIG. 4. SDS-PAGE analysis of PIB expression. (A) N. gonorrhoeae strains (5  107 CFU/ml) containing either the FA1090 (WT) or a mutant
(K120, D120 D121, or P120 P121) PIB protein were incubated at 80°C for 5 min in Laemmli loading buffer and subjected to SDS-PAGE.
(B) Approximately 4 g of outer membranes prepared from the strains described in the legend to panel A was incubated in Laemmli loading buffer
at either 23 or 80°C for 5 min prior to electrophoresis. Proteins were stained with Coomassie brilliant blue. Arrows indicate porin monomers
(M) and trimers (T).
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channel (14). Recently, the structure of the Comomonas ac-
idovorans Omp32 porin, which has higher homology to gono-
coccal PIB than other porins whose structures are known, was
solved at a resolution of 2.1 Å (45). The amino acids of the C.
acidovorans Omp32 monomer that correspond to N. gonor-
rhoeae PIB residues 120 and 121, as determined from an align-
ment of these two porin protein sequences, are Thr-102 and
Ser-103. In the crystal structure of Omp32, these two residues
are located on a small 	-helix in loop 3 with their side chains
pointing into the channel, in an ideal position to affect the
permeation of antibiotics. Gill et al. (20) predicted that resi-
dues in loop 3 of PIB were important for mediating resistance
to antibiotics, although no supporting evidence was presented.
We have confirmed and extended their work, and we show that
residues 120 and 121 in loop 3 are responsible for conferring
porin-mediated resistance to both penicillin and tetracycline.
Crystal structures of Rhodobacter capsulatus and E. coli por-
ins were the first to show that loop 3 folds into the barrel and
constricts pore size (12, 43). The importance of loop 3 in the
permeation, ion conductance, and ion selectivity of several
porins has been investigated in detail. These studies have re-
lated alterations in the constriction loop to changes in pore
properties. Specifically, studies with the phosphate starvation-
induced E. coli porin PhoE revealed that mutation of a single
lysine residue (Lys-125) to glutamic acid in loop 3 reverses ion
selectivity from anionic to cationic and inhibits interaction with
polyphosphate (1). Deletions and site-directed mutagenesis of
loop 3 in E. coli OmpF and OmpC resulted not only in changes
in ion selectivity but also in changes in sugar permeation and
antibiotic susceptibility (28, 31, 33, 36). As with the PIB of N.
gonorrhoeae, mutations in loop 3 of E. aerogenes porin con-
ferred reduced susceptibility to cephalosporins (10). In vitro
studies with E. coli porins have shown that mutations in the
barrel also confer altered antibiotic susceptibilities and pore
properties (31, 33, 36). It is not clear whether residues other
than 120 and 121 in PIB contribute to antibiotic resistance in
clinical strains of N. gonorrhoeae; however, our data suggest
that mutations in loop 3 are the predominant means by which
intermediate-level resistance to penicillin and tetracycline is
conferred in penB strains.
Antibiotic resistance in both laboratory and clinical strains
of N. gonorrhoeae has been linked to PIB serovars and not to
PIA (44). This may be because an aspartate residue at position
120 in PIA confers only modest resistance to penicillin and no
resistance to tetracycline over that of wild-type PIA. However,
the mechanism underlying the differential susceptibility to tet-
racycline and penicillin observed in this mutant is currently
unknown. The PIA sequences from clinical isolates in the Gen-
Bank database show only a glycine or an aspartate at this
position. However, since a G120K mutation in PIA confers
modest levels of resistance to penicillin and tetracycline over
those of wild-type PIA, it is intriguing that a lysine mutation
has not developed naturally in PIA proteins. Reasons for this
may include biological differences between PIA and PIB pro-
teins, which may contribute to differing selection pressures,
including infection localization and serum resistance proper-
ties (3, 6).
The mechanism(s) by which the mutations in loop 3 of N.
gonorrhoeae PIB confer antibiotic resistance is presently un-
known. Gill et al. (20) speculated that aspartic acid residues in
FIG. 5. Alignment of PIA and PIB protein sequences. PIA and PIB proteins from strains FA19 and FA1090, respectively, were aligned with
the Clustal-X program (41). The figure was generated from the aligned sequences by the Boxshade program (available on the World Wide Web).
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loop 3 of the FA140 PIB decrease antibiotic flux via anionic
repulsion. However, we believe this mechanism is unlikely,
since we show in this study that a basic lysine residue at posi-
tion 120 also mediates intermediate-level resistance to both
penicillin and tetracycline. Our data suggest that mutations at
residues 120 and/or 121 in PIB alter the conformation of loop
3 to decrease the flux of antibiotics into the periplasmic space.
This model is further supported by the recovery of a penB
transformant with proline residues in this region, which are
known to perturb protein structure due to the incorporation of
a secondary amide linkage into the peptide backbone. Previous
studies also have shown that expression of the penB phenotype
in the gonococcus depends on prior acquisition of the mtr
resistance gene (39). Electrophysiological and biochemical
studies of purified PIB proteins to address the mechanism of
resistance to penicillin and tetracycline conferred by mutations
in PIB and the apparent synergism between mtr and penB are
currently in progress.
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